NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events
Research Theme

Respiratory

You are here: Home > News listings for Respiratory

News for Respiratory

OUH agrees long COVID research collaboration with Polarean

11 May 2022 · Listed under COVID-19, Imaging, Respiratory

Oxford University Hospitals (OUH) and the medical imaging technology company, Polarean Imaging plc, have entered into a research collaboration to study the long-term effects of COVID-19 in patients who are still experiencing breathlessness months after infection.  Polarean produce an investigational drug‑device combination product using hyperpolarised xenon gas to enhance magnetic resonance imaging (MRI) in pulmonary medicine. … Read more

Oxford BRC researchers named NIHR Senior Investigators

3 March 2022 · Listed under Clinical Informatics and Big Data, Gastroenterology and Mucosal Immunity, Musculoskeletal, Respiratory, Surgical Innovation and Evaluation

Seven Oxford academics, six of them supported by the NIHR Oxford Biomedical Research Centre (BRC), have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their outstanding leadership in research. The NIHR describes its Senior Investigators as among the “most prominent and prestigious researchers” and “most outstanding leaders of patient and people-based research within … Read more

People with long COVID after hospitalisation face limited recovery after one year

16 December 2021 · Listed under COVID-19, Imaging, Respiratory

People who were hospitalised with COVID-19 and continued to experience symptoms five months later show limited further recovery one year after hospital discharge, according to the latest results of a major national study looking at the long-term health impacts of COVID-19 on hospitalised patients The latest findings of the PHOSP-COVID study, which involves several researchers … Read more

Second study confirms benefits of budesonide in early stages of COVID-19

12 August 2021 · Listed under COVID-19, Respiratory

A UK-wide clinical study has confirmed the findings of an earlier Oxford BRC-supported study showing that the early treatment with the inhaled asthma medication budesonide speeds up recovery from COVID-19 and reduces the risk of hospitalisation and death. The latest study – part of the PRINCIPLE trial, which is looking at potential treatments for COVID-19 … Read more

Study confirms longer-term lung damage after COVID-19

25 May 2021 · Listed under COVID-19, Imaging, Respiratory

A study by Oxford and Sheffield researchers using a cutting-edge method of imaging has identified persistent damage to the lungs of COVID-19 patients at least three months after they were discharged from hospital, and for some patients even longer. This damage was not detected by routine CT scans and clinical tests, and the patients would … Read more

Azithromycin not effective against COVID-19, trial confirms

26 April 2021 · Listed under COVID-19, Respiratory

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19. The ATOMIC2 trial, which was supported by the NIHR Oxford Biomedical Research Centre (BRC), was established to investigate if a common antibiotic called azithromycin could prevent patients with mild-moderate COVID-19 from getting … Read more

National study looks at long-term lung damage from COVID-19

7 April 2021 · Listed under COVID-19, Respiratory

A new national study involving researchers from Oxford will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability. Many people recovering from COVID-19 suffer from long-term symptoms of lung damage, including breathlessness, … Read more

Risk of severe COVID-19 from asthma and other respiratory diseases may be only modestly increased, new analysis suggests

1 April 2021 · Listed under Clinical Informatics and Big Data, COVID-19, Obesity, Diet and Lifestyle, Respiratory

An analysis of 8.3 million health care records in England shows that people with asthma have only a small increased risk of developing severe Covid-19. The study, led by University of Oxford researchers, examined routine patient data collected between January and April 2020 to generate risk assessments for severe COVID-19 in people with chronic respiratory … Read more

Seven in ten patients hospitalised with COVID-19 not fully recovered five months after discharge

24 March 2021 · Listed under Cardiovascular, COVID-19, Imaging, Respiratory

A majority of survivors who left hospital following COVID-19 had not fully recovered five months after discharge and continued to experience negative impacts on their physical and mental health, as well as their ability to work, according to results released by a major national study into the longer-term effect of the COVID-19. The PHOSP-COVID study, … Read more

Drug trial that could improve respiratory recovery from COVID-19 under way

10 February 2021 · Listed under COVID-19, Respiratory

A clinical trial has begun to test whether the drug Almitrine can help people who are seriously ill with COVID-19 recover from the disease. Oxford University Hospitals NHS Foundation Trust is one of three centres taking part in the trial. Patients suffering from COVID-19 pneumonia often develop very low levels of oxygen, called hypoxia, in … Read more

Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests

8 February 2021 · Listed under COVID-19, Respiratory

Early treatment with a medication commonly used to treat asthma appears to significantly reduce the need for urgent care and hospitalisation in people with COVID-19, researchers at the University of Oxford have found. The STOIC study found that inhaled budesonide given to patients with COVID-19 within seven days of the onset of symptoms also reduced … Read more

Interferon-b trial shows positive results

16 November 2020 · Listed under COVID-19, Respiratory

A trial of a new inhaled antiviral drug for COVID-19 has shown positive results and the drug is now moving into a larger international phase 3 trial of hospitalised patients, which is to be delivered with support from the NIHR. The new treatment, a protein called interferon beta or SNG001, has been developed by the UK biotech … Read more

‘Awake proning’ associated with improved COVID-19 clinical outcomes

15 September 2020 · Listed under COVID-19, Respiratory

A study by Oxford respiratory researchers has found that putting COVID-19 patients in a prone position can lead to improved outcomes. The findings of this retrospective study, supported by the NIHR Oxford Biomedical Research Centre, were published in an article by BMJ Open Respiratory Research. Outcomes for patients with COVID-19 who require mechanical ventilation are … Read more

Oxford University and ZOE partner on COVID-19 treatment trials

3 August 2020 · Listed under COVID-19, Multimorbidity and Long-Term Conditions, Respiratory

The University of Oxford has joined forces with the COVID Symptom Study app to widen access to two clinical trials of potential treatments for COVID-19.  The two trials include the STOIC trial, which is supported by the NIHR Oxford BRC. Run by the University’s Nuffield Department of Medicine (NDM), it is aiming to learn if … Read more

New treatment reduces COVID-19 patients needing intensive care

20 July 2020 · Listed under Respiratory

The preliminary results of a clinical trial supported by NIHR Oxford BRC researchers have suggested that a new treatment for COVID-19 dramatically reduces the number of patients needing intensive care. The treatment, a protein called interferon beta, has been developed by the UK biotech company Synairgen and a team of scientists at the University of … Read more

New national study into the long-term health impacts of COVID-19

8 July 2020 · Listed under COVID-19, Imaging, Other News, Respiratory

A major UK research study – PHOSP-COVID, will investigate the long-term health impacts of COVID-19 on hospitalised patients. The new study has been awarded £8.4 million jointly by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR). The PHOSP-COVID study is one of a number of COVID-19 studies that have been … Read more

First patient recruited for key drug treatment trial

4 June 2020 · Listed under COVID-19, Respiratory

A clinical trial to test whether Azithromycin, a commonly used antibiotic, can treat the symptoms of COVID-19 in outpatients has recruited its first patient. The ATOMIC2 trial, which is being led from Oxford, will enrol 800 people who are being assessed at hospital with COVID-19 but felt well enough to be cared for at home. … Read more

Drug trial could lead to enhanced respiratory care for COVID-19 patients

29 May 2020 · Listed under COVID-19, Respiratory

Researchers at the University of Oxford are working with clinical collaborators from NHS hospitals, including Oxford University Hospitals, to test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen levels is important in COVID-19, because many patients with the disease die … Read more

BRC funds new COVID-19 research projects

6 April 2020 · Listed under COVID-19, Imaging, Multimorbidity and Long-Term Conditions, Respiratory, Technology and Digital Health

The NIHR Oxford Biomedical Research Centre (BRC) has allocated funding to three COVID-19 research projects in an attempt to improve treatment, understand how the virus interacts with chronic diseases, and the longer-term effects of infection on organs. The funding, originally earmarked for BRC cross-theme cluster projects, has been diverted to research projects in the BRC’s … Read more

Oxford researchers to play key role in fight-back against COVID-19

20 March 2020 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19, Gastroenterology and Mucosal Immunity, Partnerships for Health, Wealth and Innovation, Respiratory, Vaccines for Emerging and Endemic Diseases

Researchers supported by the NIHR Oxford Biomedical Research Centre will play a crucial role in tackling the current COVID-19 pandemic, ranging from the development of a new vaccine to developing the most effective drug treatments for people who have contracted the virus. A team from the Oxford Vaccine Group and the University of Oxford’s Jenner … Read more

  • 1
  • 2
  • Next Page »

Respiratory Theme

  • Introduction
  • Sub-Theme: Inflammatory airways disease
  • Sub-Theme: Stratification of lung disease
  • Sub-Theme: Lung infection
  • PPI Case Study
  • Contacts
  • Videos for this theme
  • News for this theme
  • General News Listings

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre